Bionano Genomics (NASDAQ:BNGO) Releases Quarterly Earnings Results, Beats Estimates By $0.22 EPS

Bionano Genomics (NASDAQ:BNGO) issued its quarterly earnings data on Thursday. The company reported ($1.59) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.81) by $0.22, FiscalAI reports. The firm had revenue of $7.37 billion during the quarter, compared to the consensus estimate of $6.91 million. Bionano Genomics had a negative net margin of 271.02% and a negative return on equity of 129.41%. Bionano Genomics updated its Q4 2025 guidance to EPS and its FY 2025 guidance to EPS.

Bionano Genomics Price Performance

Shares of NASDAQ:BNGO traded up $0.14 during trading on Friday, hitting $1.61. 610,904 shares of the company’s stock were exchanged, compared to its average volume of 321,088. The business’s 50-day simple moving average is $2.13 and its 200 day simple moving average is $3.05. The company has a market cap of $6.64 million, a price-to-earnings ratio of -0.07 and a beta of 2.13. Bionano Genomics has a 52-week low of $1.47 and a 52-week high of $22.80. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.76 and a quick ratio of 1.41.

Analysts Set New Price Targets

Several equities analysts recently weighed in on BNGO shares. Wall Street Zen upgraded Bionano Genomics from a “sell” rating to a “hold” rating in a research report on Monday, August 25th. HC Wainwright reaffirmed a “buy” rating and set a $11.00 price objective (up from $10.00) on shares of Bionano Genomics in a research report on Monday, August 18th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Bionano Genomics in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $7.50.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.